Kristof Van de Voorde

Kristof Van de Voorde

Auto-generated profile, based on publicly available information

Kristof Van de Voorde

Department of Cardiac Surgery, University Hospitals Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
JBJanne Brouckaert
Janne Brouckaert
KVKatrien Vandendriessche
Katrien Vandendriessche
KDKarlien Degezelle
Karlien Degezelle
KVKristof Van de Voorde
Kristof Van de Voorde
FBFrancis De Burghgraeve
Francis De Burghgraeve
FRFilip Rega
Filip Rega

8 January 2026 in JTCVS Techniques
Verified
Journal Article
Open access
MOMichaela Orlitová
Michaela Orlitová
PCPiet Claus
Piet Claus
DBDieter van Beersel
Dieter van Beersel
AKAnna E. Kaiser-Frick
Anna E. Kaiser-Frick
AVArno Vanstapel
Arno Vanstapel
TVTom Verbelen
Tom Verbelen
Bilateral lung transplantation might require venoarterial extracorporeal membrane oxygenation for intraoperative support. However, the impact of extracorporeal life support modalities on right ventricular function and pulmonary ischemia-reperfusion injury remains poorly understood. This study aimed to compare the effects of passive and active extracorporeal life support strategies on right ventricular performance, pulmonary injury, and systemic inflammation. By using a validated porcine surrogate bilateral lung transplantation model, animals were divided into 3 groups: no extracorporeal life support group (clamping, n = 9), passive extracorporeal circuit group without a mechanical pump but with a low-resistance oxygenator (pulmonary artery to left atrium bypass strategy, n = 7) between the pulmonary artery and left atrium, and a centrally cannulated venoarterial extracorporeal membrane oxygenation group (n = 7). Pulmonary injury, hemodynamic parameters, and inflammatory markers were comprehensively assessed. Pulmonary edema was greater in extracorporeal membrane oxygenation versus a pulmonary artery to left atrium bypass strategy (wet-to-dry weight ratio, P = .0315). Right ventricular failure occurred in 5 of 9 animals in the clamping group but was absent in both pulmonary artery to left atrium bypass and extracorporeal membrane oxygenation groups. Extracorporeal membrane oxygenation led to significantly higher right ventricular afterload compared with clamping and pulmonary artery to left atrium bypass (arterial elastance, P = .0001 and P < .0001, respectively). Systemic inflammation appeared highest in extracorporeal membrane oxygenation, as reflected by interleukin-6 levels (clamping vs pulmonary artery to left atrium bypass strategy P = .0004; clamping vs extracorporeal membrane oxygenation P < .0001; pulmonary artery to left atrium bypass strategy vs extracorporeal membrane oxygenation P = .0004). Both pulmonary artery to left atrium bypass and extracorporeal membrane oxygenation prevented right ventricular failure in a setting of severe pulmonary ischemia-reperfusion injury. Our results suggest that pulmonary artery to left atrium bypass might provide better pulmonary protection and cause less inflammation than extracorporeal membrane oxygenation. These findings may guide further investigation of pumpless extracorporeal life support strategies for lung transplantation.